Abstract

The cell division cycle 25 phosphatases CDC25A, B and C regulate cell cycle transitions by dephosphorylating residues in the conserved glycine-rich loop of CDKs to activate their activity. Here, we present the cryo-EM structure of CDK2-cyclin A in complex with CDC25A at 2.7 Å resolution, providing a detailed structural analysis of the overall complex architecture and key protein-protein interactions that underpin this 86 kDa complex. We further identify a CDC25A C-terminal helix that is critical for complex formation. Sequence conservation analysis suggests CDK1/2-cyclin A, CDK1-cyclin B and CDK2/3-cyclin E are suitable binding partners for CDC25A, whilst CDK4/6-cyclin D complexes appear unlikely substrates. A comparative structural analysis of CDK-containing complexes also confirms the functional importance of the conserved CDK1/2 GDSEID motif. This structure improves our understanding of the roles of CDC25 phosphatases in CDK regulation and may inform the development of CDC25-targeting anticancer strategies.

CDC25 phosphatases are attractive anticancer drug targets that regulate CDK activity. Here, the authors present the cryo-EM structure of the CDK2-cyclin A-CDC25A complex at 2.7 Å resolution, detailing key protein-protein interactions.

Details

Title
Cryo-EM structure of the CDK2-cyclin A-CDC25A complex
Author
Rowland, Rhianna J. 1   VIAFID ORCID Logo  ; Korolchuk, Svitlana 2 ; Salamina, Marco 3   VIAFID ORCID Logo  ; Tatum, Natalie J. 1   VIAFID ORCID Logo  ; Ault, James R. 4 ; Hart, Sam 5   VIAFID ORCID Logo  ; Turkenburg, Johan P. 5   VIAFID ORCID Logo  ; Blaza, James N. 5   VIAFID ORCID Logo  ; Noble, Martin E. M. 1   VIAFID ORCID Logo  ; Endicott, Jane A. 1   VIAFID ORCID Logo 

 Framlington Place, Translational and Clinical Research Institute, Newcastle University Centre for Cancer, Newcastle University, Paul O’Gorman Building, Newcastle upon Tyne, UK (GRID:grid.1006.7) (ISNI:0000 0001 0462 7212) 
 Framlington Place, Translational and Clinical Research Institute, Newcastle University Centre for Cancer, Newcastle University, Paul O’Gorman Building, Newcastle upon Tyne, UK (GRID:grid.1006.7) (ISNI:0000 0001 0462 7212); Stockton-on-Tees, Fujifilm, Belasis Ave, Billingham, UK (GRID:grid.434589.7) (ISNI:0000 0004 4662 2622) 
 Framlington Place, Translational and Clinical Research Institute, Newcastle University Centre for Cancer, Newcastle University, Paul O’Gorman Building, Newcastle upon Tyne, UK (GRID:grid.1006.7) (ISNI:0000 0001 0462 7212); Milton, Evotec (UK) Ltd., Abingdon, UK (GRID:grid.448222.a) (ISNI:0000 0004 0603 4164) 
 University of Leeds, Astbury Centre for Structural Molecular Biology, School of Molecular and Cellular Biology, Leeds, UK (GRID:grid.9909.9) (ISNI:0000 0004 1936 8403) 
 Heslington, York Structural Biology Laboratory and York Biomedical Research Institute, Department of Chemistry, University of York, York, UK (GRID:grid.5685.e) (ISNI:0000 0004 1936 9668) 
Pages
6807
Publication year
2024
Publication date
2024
Publisher
Nature Publishing Group
e-ISSN
20411723
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
3091019078
Copyright
© The Author(s) 2024. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.